Last update Oct. 21, 2023
It is a low potency non-steroidal anti-inflammatory drug (NSAID) derived from anthranilic acid similar to mefenamic acid. It is used to treat mild to moderate pain in rheumatoid arthritis and osteoarthritis, dysmenorrhea and menorrhagia. It is administered orally in 3 to 4 daily doses.
On latest update no published data about breastfeeding were found
Its high plasma protein binding makes excretion into breast milk unlikely
Until more information on this drug concerning breastfeeding is available, a safer alternative is preferred.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Confederación Nacional de Pediatría (CONAPEME) of Mexico
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM